STOCK TITAN

ORTHOPEDIATRICS (KIDS) SEC Filings, Aug 5-25, 2025

KIDS NASDAQ

OrthoPediatrics Corp. filings document the regulatory record of a Nasdaq-listed medical device company focused on pediatric orthopedics. Its Form 8-K reports include quarterly and annual results, unaudited financial statements, revenue trends across Trauma and Deformity, Scoliosis, Sports Medicine/Other and OrthoPediatrics Specialty Bracing, as well as management guidance and investor presentation materials furnished under Regulation FD.

The company’s filings also cover governance and ownership matters through proxy statements, including board elections, executive compensation and equity awards. Material-event filings describe financing arrangements such as amendments to credit agreements and delayed draw term loan capacity, tying capital structure disclosures to the company’s operating and liquidity needs.

Rhea-AI Summary

OrthoPediatrics Corp. (KIDS) Form 4: Chief Operating Officer and Chief Financial Officer Fred Hite purchased 5,076 shares of OrthoPediatrics common stock in the open market on 08/21/2025 at $19.41 per share, bringing his beneficial ownership to 213,065 shares including 150,360 restricted shares. The filing notes the purchase was matchable under Section 16(b) with a prior sale, and Mr. Hite disgorged $27,664.20 to the company representing the full short-swing profit.

The transaction was reported by an attorney-in-fact on 08/25/2025. The Form 4 shows direct ownership and does not report derivative transactions. No additional executive departures, changes in compensation, or forward-looking statements are included in the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
insider
-
Rhea-AI Summary

OrthoPediatrics announced the Board accepted the resignation of director Terry Schlotterback due to retirement, effective August 8, 2025; the filing states the departure was not due to any disagreement with the Company. The Board appointed Kelly Fischer to fill the vacancy and to serve in the director class expiring at the annual stockholder meeting in 2026. Ms. Fischer has been Senior Vice President and Chief Financial Officer of Cook Medical since 2003 and will join the Board's Audit Committee and Compensation Committee.

For her service, Ms. Fischer will be eligible to receive a pro rata portion of the 2025 Award under the Company's Non-Employee Director Compensation Policy (described in Exhibit 10.1 to a recent Quarterly Report). The Board also agreed that the remaining 10,900 unvested restricted shares previously granted to Mr. Schlotterback will remain outstanding and continue to vest on their scheduled timelines as though he remained a director. The company disclosed no material plans, contracts or related-party transactions involving Ms. Fischer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
current report
-
Form 10-Q
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.34%
Tags
quarterly report
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.34%
Tags
current report
-
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.34%
Tags
current report
-
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.34%
Tags
current report

FAQ

How many ORTHOPEDIATRICS (KIDS) SEC filings are available on StockTitan?

StockTitan tracks 66 SEC filings for ORTHOPEDIATRICS (KIDS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ORTHOPEDIATRICS (KIDS)?

The most recent SEC filing for ORTHOPEDIATRICS (KIDS) was filed on October 28, 2026.